| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |